| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |